A Comparison of Planned Dose in TBI VMAT Treatment with Dosimetry Using Portal Dosimetry® and IBA MatriXX®
DOI:
https://doi.org/10.15392/2319-0612.2024.2683Keywords:
Portal Dosimetry, IBA MatriXX, BMT, TBI, VMATAbstract
Bone Marrow Transplant (BMT) is an essential therapeutic intervention in the treatment of diseases such as leukemia and lymphoma, where Total Body Irradiation (TBI) plays a crucial role by eradicating residual diseases and inducing immunosuppression, thus facilitating cell transplantation and reducing the risk of graft rejection. Traditionally, TBI has used large radiation fields, which can lead to significant toxicities in organs at risk (OARs) due to challenges in dose optimization. Volumetric Modulated Arc Therapy (VMAT) emerges as a promising technique, offering advantages such as the use of smaller treatment spaces and reduced doses to OARs, which may improve patient quality of life and reduce treatment costs. This study evaluates the effectiveness of VMAT in TBI by comparing the planned dose with the dose measured by quality control systems, such as the MatriXX FFF from IBA and the Portal Dosimetry from the VitalBeam linear accelerator, demonstrating that VMAT is a viable and effective alternative with the potential to optimize therapeutic outcomes in BMT.
Downloads
References
[1] CASTRO JR, C. G.; GREGIANIN, L. J.; BRUNETTO, A. L. Transplante de medula óssea e transplante de sangue de cordão umbilical em pediatria. Jornal de Pediatria, v. 77, p. 345-360, 2001.
[2] CORGOZINHO, M. M.; GOMES, J. R. A. A.; GARRAFA, V. Transplantes de medula óssea no Brasil: dimensão bioética. Revista Latinoamericana de Bioética, v. 12, n. 1, p. 36-45, 2012.
[3] DYK, J. V. et al. AAPM Report No. 17: The Physical Aspects of Total and Half Body Photon Irradiation. American Association of Physicists in Medicine, 1986.
[4] QUAST, Ulrich. Whole body radiotherapy: A TBI-guideline. Journal of medical physics, v. 31, n. 1, p. 5-12, 2006.
[5] VOGEL, J. et al. Pulmonary toxicity after total body irradiation–critical review of the literature and recommendations for toxicity reporting. Frontiers in Oncology, v. 11, p. 708906, 2021.
[6] PETERS, M.; TAYLOR, B.; TURNER, E. An evidence-based review of total body irradiation. Journal of medical imaging and radiation sciences, v. 46, n. 4, p. 442-449, 2015.
[7] Sampath, S., Schultheiss, T., & Wong, J. (2005, Nov 1). Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Radiat Oncol Biol Phys, p. 63(3). doi: 10.1016/j.ijrobp.2005.02.032
[8] TAS, B. et al. Dosimetric evaluation of total body irradiation (TBI) treatment by volumetric modulated arc therapy (VMAT) on the coach. Journal of Biochemistry and Biophysics, v. 1, n. 1, p. 103, 2017.
[9] ZHANG-VELTEN, Elizabeth Ren et al. Volumetric modulated arc therapy enabled total body irradiation (VMAT-TBI): six-year clinical experience and treatment outcomes. Transplantation and cellular therapy, v. 28, n. 2, p. 113. e1-113. e8, 2022.
[10] MUÑOZ-MORAL, E.; RODRÍGUEZ-LAGUNA, A.; JIMÉNEZ-ACOSTA, J. A. Implementation of total body irradiation using VMAT. In: AIP Conference Proceedings. AIP Publishing, 2021
[11] TERUEL, J. R. et al. Automatic treatment planning for VMAT‐based total body irradiation using Eclipse scripting. Journal of Applied Clinical Medical Physics, v. 22, n. 3, p. 119-130, 2021.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2024 Juan Sousa, I Lima, D Olbi, Lucas Nascimento, Andre Fidelis, Maria Luiza Maciel, Luiz da Rosa, Simone Coutinho Cardoso
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing: The BJRS articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/